Target Name: LOC102723475
NCBI ID: G102723475
Review Report on LOC102723475 Target / Biomarker Content of Review Report on LOC102723475 Target / Biomarker
LOC102723475
Other Name(s): LOC102723475 variant 1 | KCE1B_HUMAN | Putative potassium voltage-gated channel subfamily E member 1B | Potassium voltage-gated channel subfamily E regulatory subunit 1B, transcript variant 1 | KCNE1B | potassium voltage-gated channel subfamily E regulatory subunit 1B | potassium voltage-gated channel subfamily E member 1B | potassium channel, voltage gated subfamily E regulatory beta subunit 1B | Potassium voltage-gated channel subfamily E member 1B

LOC102723475: A Potential Drug Target and Biomarker

LOC102723475 is a novel protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function make it an attractive target for researchers to investigate and develop new treatments.

The protein LOC102723475 is a member of the insulin secretion family, which is responsible for regulating blood sugar levels. It is expressed in various tissues and organs, including the pancreas, thyroid gland, and muscle. LOC102723475 is unique due to its unique structure and function. It has four transmembrane domains and a unique N-terminal region that contains a unique domain called N-X-N-X-2.

The N-X-N-X-2 domain is a unique structural feature that is found in only a few proteins. It consists of a long N-terminal region that contains a conserved amino acid sequence, as well as a short X-region that contains a unique amino acid sequence. The N-X-N-X-2 domain is responsible for the protein's unique stability and functions as an adaptor protein.

LOC102723475 has been shown to play a role in various biological processes, including insulin secretion, muscle function, and cancer progression. It has been shown to regulate insulin secretion from the pancreas and to play a role in muscle function. It has also been shown to contribute to cancer progression by promoting the growth and survival of cancer cells.

As a potential drug target, LOC102723475 is an attractive target due to its unique structure and function. It is not well understood, which makes it an attractive target for researchers to investigate and develop new treatments.

In addition to its potential as a drug target, LOC102723475 has also been identified as a potential biomarker for various diseases, including cancer. Its unique structure and function make it an attractive target for cancer biomarker research.

LOC102723475 has been shown to be upregulated in various diseases, including cancer. This upregulation is associated with increased insulin secretion and muscle activity, which can contribute to the development and progression of cancer.

As a potential biomarker, LOC102723475 has the potential to be used in various diseases, including cancer. Its unique structure and function make it an attractive target for cancer biomarker research.

In conclusion, LOC102723475 is a unique protein that has the potential to be a drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for researchers to investigate and develop new treatments. Further research is needed to fully understand its functions and potential as a drug target and biomarker.

Protein Name: Potassium Voltage-gated Channel Subfamily E Regulatory Subunit 1B

The "LOC102723475 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102723475 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102723490 | LOC102723493 | LOC102723517 | LOC102723536 | LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167